AzTrials
AzTrials

Psychological Well-beingPhase 2/3NCT01352325

Efficacy of System Constellations in a General Population

A Phase 2/3 study testing system constellations seminar in people with Psychological Well-being, run by Heidelberg University at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to investigate the efficacy of system constellations in a monocentric, single-masked randomized controlled trial. The method of system constellations refers to an approach which integrates ideas from family systems therapy with elements from psychodrama. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Psychological Well-being
What is being tested?
system constellations seminar
Could I receive a placebo?
No, everyone receives an active treatment
How many people
216 participants
Where
1 siteGermany
Study dates
Feb 2011to Dec 2011
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • agreement to participate in a 3-day system constellations seminar
  • agreement to be randomized into treatment group or control group (waiting condition)
  • agreement not to participate in another system constellation seminar until completion of study

Who cannot join

  • acute suicidal tendency
  • acute psychotic episode
  • acute drug or alcohol intoxication

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Institute of Medical Psychology, University Hospital Heidelberg

    Heidelberg, Baden-Wurttemberg, 69115

Other trials in Germany

About this study

Official title: Randomized Controlled Trial on the Efficacy of System Constellations on Psychological Well-being in a General Population Based Sample

The purpose of this study is to investigate the efficacy of system constellations in a monocentric, single-masked randomized controlled trial.

The method of system constellations refers to an approach which integrates ideas from family systems therapy with elements from psychodrama. The constellations are conducted in a group based seminar-setting, each seminar lasting three days.

Based on the model of a general psychotherapy and the consistency theory, the effects of system constellations on psychological functioning are explored.

It is predicted that participation in a system constellation seminar changes the level of psychological functioning at 4 months.

Being tested
system constellations seminar
Medical subject headings
Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • system constellations seminarBehavioural

    individual-centered intervention in a group setting, duration 3 days

  • system constellations seminarBehavioural

    individual-centered intervention in a group setting, duration 3 days

Study groups in NCT01352325
Study groupRoleWhat they receive
system constellations seminar (exp. group)ExperimentalStudy participants randomized to this group receive the intervention (system constellation seminar) 4 months prior to the control group
Receives: Behavioral: system constellations seminar
system constellations seminar (control group)ExperimentalStudy participants randomized to this group receive the intervention (system constellations seminar) 4 months after the experimental group.
Receives: Behavioral: system constellations seminar

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from Baseline in psychological well-being at 2 weeks and four months

    Psychological well-being will be assessed using the 'Outcome Questionnaire' in its German version (EB-45). The EB-45 is a brief 45-item self report outcome/tracking instrument designed for repeated measurement of client progress through the course of psychotherapy and following termination. The scales of the EB-45 measure symptom distress, interpersonal functioning, and social role.

    Measured: Baseline, day of treatment, 2 weeks after treatment, 4 months after treatment

Secondary outcomes (4)
  1. Change from Baseline in Psychological distress after 2 weeks and 4 months

    The FEP-2, 40-item self report questionnaire, measures psychological distress according to the phase model of therapeutic change as well as the interpersonal model of psychological distress.

    Measured: Baseline, day of treatment, 2 weeks after treatment, 4 months after treatment

  2. Change from Baseline in Incongruence at 2 weeks and 4 months

    Motivational incongruence is defined as the unsatisfactory realization of motivational goals and is based on the concept of General Psychotherapy by Klaus Grawe. The Incongruence Questionnaire (INK) is an instrument that assesses motivational incongruence, defined as the discrepancy between a person's motivational goals and his/her perception of reality. The short version of this questionnaire that will be used in our study (K-INK) comprises 23 items.

    Measured: Baseline, day of treatment, 2 weeks after treatment, 4 months after treatment

  3. Goal achievement at 2 weeks and 4 months

    Goal achievement will be assessed using Goal Attainment Scaling as a method for the assimilation of achievement in a number of individually set goals into a single aggregated 'goal attainment score', providing a person-centred outcome, focused on that individual's priorities. Goal attainment scaling is operationalized by an open-ended question, in which study participants descriobe their individual goals. In a second step these goals will be coded according to the Bern inventory of psychotherapy goals (BIT-C).

    Measured: day of treatment, 2 weeks after treatment, 4 months after treatment

  4. Change from Baseline in 'Experiences in family and organisational systems' at 2 weeks and 4 months

    The subjective quality of family and organizational systems will be assessed by the HFES (Heidelberger Fragebogen zum Erleben in Systemen: Heidelberg Questionnaire on experiences in systems), a self-constructed questionnaire comprising 24 items.

    Measured: day of treatment, 2 weeks after treatment, 4 months after treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 May 2011 (estimated)
  2. Study startFeb 2011
  3. Primary completionDec 2011
  4. Study completionDec 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
216 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01352325
Sponsor's protocol ID
SFBC11
Other IDs
SFB 619 project C11
Status last verified
Feb 2012
First submitted
4 May 2011
Last updated
9 Feb 2012
Results posted
No
Data monitoring committee
Yes

Publications

  • Hunger C, Bornhauser A, Link L, Schweitzer J, Weinhold J. Improving experience in personal social systems through family constellation seminars: results of a randomized controlled trial. Fam Process. 2014 Jun;53(2):288-306. doi: 10.1111/famp.12051. Epub 2013 Nov 19.

    PubMed 24251855

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing system constellations seminar in people with Psychological Well-being, run by Heidelberg University at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Feb 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from Baseline in psychological well-being at 2 weeks and four months (time frame: Baseline, day of treatment, 2 weeks after treatment, 4 months after treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01352325, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Feb 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in